Arcataur Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$665K Buy
5,177
+87
+2% +$10.2K 0.16% 52
2026
Q1
$612K Sell
5,090
-10
-0.2% -$1.15K 0.17% 57
2025
Q4
$537K Buy
5,100
+251
+5% +$23.6K 0.15% 61
2025
Q3
$407K Buy
4,849
+400
+9% +$32.9K 0.12% 75
2025
Q2
$352K Hold
4,449
0.11% 81
2025
Q1
$399K Sell
4,449
-252
-5% -$23.5K 0.14% 73
2024
Q4
$468K Buy
4,701
+1,025
+28% +$106K 0.16% 64
2024
Q3
$417K Buy
3,676
+65
+2% +$7.72K 0.14% 73
2024
Q2
$447K Hold
3,611
0.16% 65
2024
Q1
$476K Hold
3,611
0.17% 57
2023
Q4
$394K Buy
3,611
+100
+3% +$10.4K 0.15% 72
2023
Q3
$361K Hold
3,511
0.15% 67
2023
Q2
$405K Buy
+3,511
New +$399K 0.17% 60

Other funds holding MRK

Arcataur Capital Management's MRK Position: Q2 2026 in Review

Arcataur Capital Management increased its Merck (MRK) stake by 1.7% in Q2 2026, buying an estimated $10.2K and bringing the position to 5,177 shares worth $665K. The position accounts for 0.16% of the portfolio, ranked #52.

Arcataur Capital Management first reported a position in MRK in Q2 2023 and has held it in 13 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Arcataur Capital Management held 5,177 shares of Merck worth $665K as of Q2 2026.
  • Arcataur Capital Management bought 87 Merck shares in Q2 2026, an estimated $10.2K.
  • Merck made up 0.16% of Arcataur Capital Management's portfolio in Q2 2026, its #52 holding.
  • Arcataur Capital Management first reported a position in Merck in Q2 2023 and has held it in 13 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Arcataur Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.